Atlas Trials

Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes

Clinical trial NCT01865318 · COMPLETED

Trial details

NCT number
NCT01865318
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 1
Start date
2006-09-01
Primary completion
2007-01-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.